Results 131 to 140 of about 21,846 (223)

Severe angioedema following dupilumab therapy for bullous pemphigoid. [PDF]

JAAD Case Rep
Mummareddy H, Han S, Shroyer W.
europepmc   +1 more source

Bullous Pemphigoid Possibly Induced by Deucravacitinib in a Patient with Psoriasis. [PDF]

Clin Cosmet Investig Dermatol
Lu X, Zhang Y, Zhang H, Tang K, Jin H.
europepmc   +1 more source

An atypical presentation of Pembrolizumab-induced bullous pemphigoid in a patient with uterine serous carcinoma. [PDF]

Gynecol Oncol Rep
Chen RY, Vasavda C, Imadojemu S, Liu SW, Campos SM.   +4 more
europepmc   +1 more source

Esophageal involvement in bullous pemphigoid: A case of blisters impeding oral intake. [PDF]

J Hosp Med
Barton N, Newman S.
europepmc   +1 more source

Bullous Pemphigoid Mimicking Infection in a Diabetic Foot: A Diagnostic Challenge. [PDF]

Plast Reconstr Surg Glob Open
Alzir MS, Alnadhairi MO, Haidarah AB, Alsarori GM, Alqawlaq AK, Badahdah HM.   +5 more
europepmc   +1 more source

Personalized Biologic Therapy for Refractory Bullous Pemphigoid: Sequential Omalizumab, Dupilumab, and Rituximab. [PDF]

Clin Cosmet Investig Dermatol
Yu L, Hu G, Zhang Q, Zhu Y, Chen L, Chen J.   +5 more
europepmc   +1 more source

Bullous pemphigoid in infancy

Australasian Journal of Dermatology
Lois Zhang, Gloria Fong, Andrew Ming, Melanie Wong   +3 more
openaire   +5 more sources

Stapokibart's clinical effectiveness in treating moderate-to-severe bullous pemphigoid in the elderly. [PDF]

Front Immunol
Du N, Wang Y, Yang J, Lv X, Min W.
europepmc   +1 more source

Abrocitinib and dupilumab bridging therapy for bullous pemphigoid with insufficient response to initial corticosteroid therapy: a case report. [PDF]

Front Immunol
Zhang H, Li L, Zhao S, Wu H, Zhu J.
europepmc   +1 more source

Mendelian Randomization and Experimental Validation Identify Key Immune Signatures in Bullous Pemphigoid. [PDF]

Clin Cosmet Investig Dermatol
Wang Z, Cui H, Meng L, Yang X, Ye J.
europepmc   +1 more source